Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ayala Pharmaceuticals Inc (EM) ADXS

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company’s lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware.


EXPM:ADXS - Post by User

User Avatar Image
(187)
•••
  • coolfooldumbguyX
Post by coolfooldumbguyon Sep 25, 2019 3:05pm
97 Views
Post# 30164145

it's a buy today for me

it's a buy today for megot it this morning for .25 cents per share,a big block of 100,000 shares,it looks like it is starting to climb back up after bottoming out,so glta shareholders but please DYODD.
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities